Sign in

CIK 0000882796 · Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
621413174
Phone
919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 4 Grant or award Director acquired 644 shares (grant or award)
  2. 4 Grant or award Director acquired 1,288 shares (grant or award)
  3. 4 Grant or award Director acquired 1,159 shares (grant or award)
  4. 4 Grant or award Director acquired 644 shares (grant or award)
  5. 4 Grant or award Director acquired 1,288 shares (grant or award)
  6. 4 Grant or award Director acquired 15,294 shares (grant or award)
  7. 4 Grant or award Director acquired 15,294 shares (grant or award)
  8. 4 Grant or award Director acquired 15,294 shares (grant or award)
  9. 4 Grant or award Director acquired 15,294 shares (grant or award)
  10. 4 Grant or award Director acquired 15,294 shares (grant or award)
  11. 4 Grant or award Director acquired 15,294 shares (grant or award)
  12. 4 Grant or award Director acquired 15,294 shares (grant or award)
  13. 4 Grant or award Director acquired 15,294 shares (grant or award)
  14. 4 Grant or award Director acquired 15,294 shares (grant or award)
  15. 4 Grant or award Director acquired 1,262 shares (grant or award)
  16. 4 Grant or award Director acquired 631 shares (grant or award)
  17. 4 Grant or award Director acquired 631 shares (grant or award)
  18. 4 Grant or award Director acquired 1,122 shares (grant or award)
  19. 4 Grant or award Director acquired 1,262 shares (grant or award)
  20. 4 Open-market sale Director sold 11,180 shares at $8.97 ($100,285)

Page 1 of 49 · 965 filings